Latest liver disease Stories
NAFLD (non-alcoholic fatty liver disease) is the most common type of liver disease in the developed world, affecting up to one-third of the US population.
With so many American's suffering from Obesity, a new discovery with soy protein could help thousands.
University of Illinois scientists report that soy protein may significantly reduce fat accumulation and triglycerides in the livers of obese persons.
University of Illinois researchers will report this week that new research shows how soy protein could significantly reduce fat accumulation and triglycerides in the livers of obese patients by partially restoring the function of a key signaling pathway in the organ.
People with nonalcoholic fatty liver disease (NALFD) who consume alcohol in modest amounts – no more than one or two servings per day – are half as likely to develop hepatitis as non-drinkers with the same condition.
Two studies presented at the International Liver Congress™ 2012 show the true impact that liver disease has across Europe.
Obese youths with particular genetic variants may be more prone to fatty liver disease, a leading cause of chronic liver disease in children and adolescents in industrialized countries.
New research found the genetic variant Patatin-like phospholipase domain containing protein-3 (PNPLA3) acting in conjunction with the glucokinase regulatory protein (GCKR) is associated with increased susceptibility to fatty liver disease in obese children.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.